Pulmonary Hypertension-Associated Right Ventricular Cardiomyocyte Remodelling Reduces Treprostinil Function
Cells · 04.12.2023 · 12 (23) · 2764
DOI: 10.3390/cells12232764 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, online erschienen am 04.12.2023. Verfasst von Aleksandra Judina und 8 weiteren Autor:innen. Beteiligte Einrichtung: Cardiac Section, National Heart and Lung Institute (NHLI), Faculty of Medicine, Imperial College London, Hammersmith Campus, Du Cane Road, London W12…. Hauptthemen laut MEDLINE: Hypertension, Pulmonary, Heart Failure. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: British Heart Foundation.
Abstract (Originalsprache)
(1) Pulmonary hypertension (PH)-associated right ventricular (RV) failure is linked to a reduction in pulmonary vasodilators. Treprostinil has shown effectiveness in PAH patients with cardiac decompensation, hinting at potential cardiac benefits. We investigated treprostinil’s synergy with isoprenaline in RV and LV cardiomyocytes. We hypothesised that disease-related RV structural changes in cardiomyocytes would reduce contractile responses and cAMP/PKA signalling activity. (2) We induced PH in male Sprague Dawley rats using monocrotaline and isolated their ventricular cardiomyocytes. The effect of in vitro treprostinil and isoprenaline stimulation on contraction was assessed. FRET microscopy was used to study PKA activity associated with treprostinil stimulation in AKAR3-NES FRET-based biosensor-expressing cells. (3) RV cells exhibited maladaptive remodelling with hypertrophy, impaired contractility, and calcium transients compared to control and LV cardiomyocytes. Combining treprostinil and isoprenaline failed to enhance inotropy in PH RV cardiomyocytes. PH RV cardiomyocytes displayed an aberrant contractile behaviour, which the combination treatment could not rectify. Finally, we observed decreased PKA activity in treprostinil-treated PH RV cardiomyocytes. (4) PH-associated RV cardiomyocyte remodelling reduced treprostinil sensitivity, inotropic support, and impaired relaxation. Overall, this study highlights the complexity of RV dysfunction in advanced PH and suggests the need for alternative therapeutic strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cardiac Section, National Heart and Lung Institute (NHLI), Faculty of Medicine, Imperial College London, Hammersmith Campus, Du Cane Road, London W12 0NN, UK.
- Department of Surgery, Dentistry, Pediatrics and Gynecology, Cardiovascular Science, The University of Verona, 37134 Verona, Italy.
- Definitely School of Life and Health Sciences, Whitelands College, University of Roehampton, Holybourne Avenue, London SW15 4JD, UK.
ORCID-Profile: Vladislav Leonov, Peter T Wright, Julia Gorelik
Förderung
- British Heart Foundation
Zitieren
APA
Judina, A., Niglas, M., Leonov, V., Kirkby, N. S., Diakonov, I., Wright, P. T., Zhao, L., Mitchell, J. A., & Gorelik, J. (2023). Pulmonary Hypertension-Associated Right Ventricular Cardiomyocyte Remodelling Reduces Treprostinil Function. Cells, 12(23), 2764. https://doi.org/10.3390/cells12232764
Vancouver
Judina A, Niglas M, Leonov V, Kirkby NS, Diakonov I, Wright PT, et al. Pulmonary Hypertension-Associated Right Ventricular Cardiomyocyte Remodelling Reduces Treprostinil Function. Cells. 2023;12(23):2764. doi:10.3390/cells12232764
BibTeX
@article{Judina2023,
author = {Judina, Aleksandra and Niglas, Marili and Leonov, Vladislav and Kirkby, Nicholas S and Diakonov, Ivan and Wright, Peter T and Zhao, Lan and Mitchell, Jane A and Gorelik, Julia},
title = {Pulmonary Hypertension-Associated Right Ventricular Cardiomyocyte Remodelling Reduces Treprostinil Function},
journal = {Cells},
year = {2023},
volume = {12},
number = {23},
pages = {2764},
doi = {10.3390/cells12232764}
}
EUVIMED